Dr Reddys Laboratories RDY
NYSE RDY
$12.62 -0.23 (-1.79%)
At close: Sep 30, 2026 · 4:00 PM EDT

Dr Reddys Laboratories (RDY) Accounts Payables (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Accounts Payables of $396.07 million in the quarter ended Jun 30, 2026, down 9.5% from $437.67 million a year earlier but up 8.4% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Accounts Payables (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories reported Accounts Payables of $356 million, down 14.6% from the prior year.

  • Annual Accounts Payables has a five-year compound annual growth rate of 1.8% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Accounts Payables came in at $417 million in the year ended Mar 31, 2025 (+12.4%), $371 million in the year ended Mar 31, 2024 (+15.2%), $322 million in the year ended Mar 31, 2023 (-4.5%) and $337 million in the year ended Mar 31, 2022 (+3.7%).
  • Quarterly Accounts Payables has ranged from $285.7 million in the quarter ended Sep 30, 2022 to $461.43 million in the quarter ended Sep 30, 2025 over the past five years.
  • On a year-over-year basis, Accounts Payables rose in six of the last eight quarters, with growth averaging 5.3%.
  • Peak year-over-year performance for Accounts Payables in the last five years was growth of 29.1% in the quarter ended Sep 30, 2023, against a decline of 21.4% in the quarter ended Jun 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $365.49 million (quarter ended Mar 31, 2026), $458.12 million (quarter ended Dec 31, 2025) and $461.43 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Dr Reddys Laboratories 10.53 Bn 9.72 Bn 396.53 Mn 396.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 396.07 Mn
Mar 31, 2026 365.49 Mn
Dec 31, 2025 458.12 Mn
Sep 30, 2025 461.43 Mn
Jun 30, 2025 437.67 Mn
Mar 31, 2025 410.22 Mn
Dec 31, 2024 426.63 Mn
Sep 30, 2024 427.14 Mn
Jun 30, 2024 408.89 Mn
Mar 31, 2024 372.31 Mn
Dec 31, 2023 373.66 Mn
Sep 30, 2023 368.78 Mn
Jun 30, 2023 337.00 Mn
Mar 31, 2023 321.69 Mn
Dec 31, 2022 316.96 Mn
Sep 30, 2022 285.70 Mn
Jun 30, 2022 305.00 Mn
Mar 31, 2022 340.08 Mn
Dec 31, 2021 326.88 Mn
Sep 30, 2021 344.85 Mn
API Access

Dr Reddys Laboratories Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=RDY&period=max&api_key=YOUR_API_KEY